Institutional members access full text with Ovid®

Possible Neonatal Herpes Simplex Virus (HSV) Acquired Postpartum from Maternal Oral HSV Reactivation after Neuraxial Morphine

De Guzman, M. Cecilia MD*; Chawla, Rupesh MD, MSc, FRCP; Duttchen, Kaylene MD, BSc (Pharm), FRCP*

doi: 10.1213/XAA.0000000000000013
Case Reports: Case Report

In this report, we describe a case of a neonatal oral herpes simplex virus (HSV) infection possibly acquired from a mother who had oral HSV reactivation in association with neuraxial morphine. Neuraxial morphine is commonly administered for postpartum analgesia after cesarean delivery. While there is evidence that neuraxial morphine increases the risks of oral HSV reactivation in parturients, there has been no report of neonatal HSV infection directly acquired from a mother who had HSV recurrence from neuraxial morphine.

From the *Department of Anesthesia, University of Calgary; and Pediatric Infectious Disease, Alberta Children’s Hospital, Calgary, Alberta, Canada.

Accepted for publication November 15, 2013.

Funding: None.

The authors declare no conflicts of interest.

Address correspondence to M. Cecilia De Guzman, MD, Department of Anesthesia, University of Calgary, C229, 1403 29th St., NW, Calgary, Alberta T2N 2T9. Address e-mail to mcdvdeguzman@gmail.com, and Kaylene Duttchen, MD, BSc (Pharm), FRCP, Department of Anesthesia, University of Calgary, C229, 1403 29th St., NW, Calgary, Alberta T2N 2T9. Address e-mail to Kaylene.duttchen@albertahealthservices.ca.

© 2014 International Anesthesia Research Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website